Japan Mega-Pension to Shift to Stocks Announcement for New Portfolio for Fund Expected Friday Afternoon
TOKYO—Japan’s welfare minister is likely to approve a new portfolio for the country’s ¥127 trillion ($1.2 trillion) pension on Friday, in a move that will have a significant impact on financial markets, according to people familiar with the matter.
The new portfolio will cut the fund’s 60% target allocation to Japanese bonds by roughly half and sharply increase weightings to Japanese stocks and foreign assets, the people said. The new allocation is expected to be announced at a news conference Friday afternoon.
The people say the shift to the new allocation will take place gradually as the fund watches market conditions closely. The Government Pension Investment Fund has already been slowly unloading its hefty domestic bondholdings in recent months.
Market participants are paying close attention to signs of an allocation shift by the giant fund, as changes in its investment stance could mean a move of trillions of yen in global financial markets. Reports of the new allocation helped push up Japan’s benchmark Nikkei Stock Average by 1.7% during the morning session Friday.
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: GPRO +15.3%, MELI +15%, SYNC +12.5%, OPLK +11.2%, BCOV +10.4%, TUES +10.3%, AXTI +9.6%, BYD +9.3%, SAM +8.9%, SGMS +8%, EHTH +6.6%, ZEN +5.9%, IMPV +5.3%, SREV +4.8%, SIMG +4.6%, CTRL +4.5%, MCHP +4.4%, GRPN +4.3%, PGH +4.1%, VCRA +3.6%, ATEN +3.1%, LNKD +3%, UVE +2.9%, CODE +2.8%, WU +2.7%, SGEN +2.6%, POWI +2.5%, EXPE +2.3%, ONNN +2.1%, NEM +2.1%
Companies trading higher in after hours in reaction to news: AXTI +9.6% (announced $5 mln stock repurchase program), SRPT +7.1% (FDA issued a statement on Duchenne muscular dystrophy; FDA reiterated its willingness to conduct a 'rolling review' of Sarepta's future NDA for eteplirsen and said it understands the 'dire urgency of the situation'), NVDQ +5.4% (announced that it and LifeCell Corporation have agreed to transfer all marketing and distribution rights to the SPY Elite System from LifeCell to NOVADAQ), CPE +5.4% (Lone Star Value disclosed a 5.1% active stake), ALSN +2.1% (announced a $500 mln stock repurchase program; increased quarterly dividend to $0.15 from $0.12 per share), BPZ +1.5% (announced a gas discovery at Onshore Block XXIII and discussions for gas sales pilot project)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: AEGR -30.4%, TRMB -15.2%, TPX -13.1%, PXLW -9.3%, DGI -4.5%, SBUX -4.4%, GMED -4.3%, TEP -3.9%, GEVA -3.7%, EPAY -2.9%, NBS -2.9%, THRX -2.8%, OFC -2.6%, FLDM -2.3%, OMCL -2.2%, LNG -2.2%, C -2.1%, NUVA -1.8%, STAA -1.7%, TRUP -1.6%, CCI -1.6%, CSLT -1.5%, CPSI -1.4%, SCSC -1.3%, GB -1.3%, ATR -1.1%, SEM -1%
Companies trading lower in after hours in reaction to news: OFC -2.6% (commenced a public offering of 4.8 mln of its common shares of beneficial interest), LQ -1.9% (filed for a 20 mln share common stock offering by selling stockholders), SYRG -1.3% (announced a $125 mln purchase agreement for Wattenberg Field assets and $230 mln in committed financing)
Closing Market Summary: Dow Jones Leads Stocks Higher
The major averages ended the Thursday session on a higher note with the Dow Jones Industrial Average (+1.3%) spending the entire day in the lead. However, the strength among blue chips masked the underperformance of high-beta chipmaker and transport stocks. Furthermore, defensively-oriented health care (+1.8%) and utilities (+2.1%) finished in the lead, suggesting a lack of strong conviction.
Shortly before the open, the advance reading of Q3 GDP revealed growth of 3.5% while the Briefing.com consensus expected an increase of 3.0%. The news contributed to a rebound in the futures market, which had been pressured by early weakness in European equities. However, markets across Europe were able to erase their losses before ending for the day.
The Dow held the lead from the start thanks to a surge in its top-weighted component. Shares of Visa (V 236.65, +21.99) soared 10.2% in reaction to a bottom-line beat and news of a $5 billion buyback.
Visa's peer, MasterCard (MA 83.13, +7.14), also had a strong showing, spiking 9.4%, after it too surpassed earnings estimates. However, the two names were unable to push the technology sector (+0.2%) ahead of the broader market as other influential components like Apple (AAPL 106.98, -0.36), Facebook (FB 74.11, -1.75), and Microsoft (MSFT 46.05, -0.57) underperformed. Chipmakers also lagged with the PHLX Semiconductor Index falling 1.2%.
The high-beta group slumped after ending yesterday's session on its 50-day average (623.74). The complex widened its October loss to 3.4% with its largest component—Intel (INTC 32.58, -1.34)—plunging 4.0%.
Elsewhere among cyclical sectors, the materials space (+0.7%) had the strongest showing while energy (-0.3%) spent the day in the red. Crude oil, which fell 1.4% to $81.10/bbl, contributed to the weakness, while Chevron (CVX 117.20, +0.06) and ExxonMobil (XOM 94.45, -0.14) ended little changed ahead of their quarterly reports.
Also of note, industrials (+0.4%) could not catch up to the broader market due to the weakness among transports. The Dow Jones Transportation Average slid 1.2% with Con-way (CNW 42.35, -2.81) diving 6.2% despite beating bottom-line estimates. Meanwhile, peer C.H. Robinson (CHRW 69.22, -2.88) tumbled 4.0% in reaction to a Credit Suisse downgrade to ‘Underperform' from ‘Neutral.'
Meanwhile on the countercyclical side, consumer staples (+0.55%) and telecom services (+0.3%) slipped behind the market in the afternoon while health care (+1.8%) and utilities (+2.1%) finished in the lead.
The health care sector was boosted by strong results from AmerisourceBergen (ABC 84.84, +5.10) and Cigna (CI 97.10, +3.10). As for biotechnology, the iShares Nasdaq Biotechnology ETF (IBB 296.70, +6.07) settled higher by 2.1%.
Treasuries notched their highs right after the GDP report before spending the session in a steady retreat. The 10-yr yield slipped one basis point to 2.31%.
Today's participation was ahead of average with 730 million shares changing hands at the NYSE.
Economic data was limited to GDP and Initial Claims:
* According to the advance estimate, GDP grew at an annualized rate of 3.5% during the third quarter while the Briefing.com consensus expected the reading to come in at 3.0%
* Real final sales jumped 4.2%, which was the largest spike since Q4 2010 * The export deficit narrowed to $409.90 billion from $460.40 billion, boosting GDP growth by 1.32 percentage points * Government spending surged 4.6%, representing the sharpest increase since Q2 2009
* Weekly Initial Claims increased to 287,000 from a revised rate of 284,000 (from 283,000) while the consensus called for a reading of 284,000
* Claims have held below the 300,000 mark for the past several weeks, suggesting payroll gains should surpass 200,000 * Continuing claims increased to 2.384 million from an upwardly revised 2.355 million (from 2.351 million)
Tomorrow, September Personal Income (consensus 0.3%), Personal Spending (consensus 0.1%), Core PCE Prices (expected 0.1%), and the Q3 Employment Cost Index (expected 0.5%) will all be released at 8:30 ET while the Chicago PMI report for October (consensus 60.0) will cross the wires at 9:45 ET. The day's data will be topped off with the final release of the Michigan Sentiment survey for October (expected 86.4).
* Nasdaq Composite +9.3% YTD * S&P 500 +7.9% YTD * Dow Jones Industrial Average +3.7% YTD * Russell 2000 -0.7% YTD
AA Nov 17 calls are seeing interest ahead of investor day next week Tuesday Nov 4 at 9:00 with 3300 contracts trading vs. open int of 262.2K, pushing implied vol up around 3 points to ~35% --we noted that a Dec 16/15 put spread traded on Oct 21 (see 10/21 14:26). Co reported earnings early October.
Gapping down In reaction to disappointing earnings/guidance: AFOP -18.1%, GLUU -17%, PRXL -14.3%, WTW -10.6%, ISIL -10.3%, ATML -10.1%, RGR -9.9%, ARAY -9.7%, HGG -9.4%, PEIX -9.2%, TGB -8.5%, BGC -7%, AUDC -7%, TRLA -6.5%, ASGN -6.4%, GTLS -5.5%, OXF -5.3%, NKA -4.5%, SFLY -4.1%, OCN -3.9%, TEX -3.5%, AKAM -3.5%, AUY -3.3%, SIMO -3.1%, OII -3%, RRC -2.8%, KRFT -2.8%, GNC -2.7%, PCRX -2.7%, FMC -2.6%, MDC -2.5%, K -2.4%, RRTS -2.3%, QGEN -2.1%, WLL -2%, MZOR -1.9%, ANR -1.9%, RFP -1.8%, AHL -1.7%, GG -1.4%, RDS.A -1.4%, BIDU -1.2%, WSTL -1.2%, RJF -1.1%, HBI -1%, ABX -1%, MDAS -1%, CGI -1%
Select EU related names showing weakness: NBG -8.2%, DB -3.5%, IRE -3.4%, SAN -3.2%, UBS -2.3%, SAP -2.2%
Select metals/mining stocks trading lower: MT -3.4%, AUY -3.3%, CLF -2.7%, RIO -2.2%, GOLD -1.8%, GG -1.4%, IAG -1.3%, ABX -1%, SA -0.8%, GFI -0.6%, NEM -0.6%
Select oil/gas related names showing early weakness: STO -2.6%, RIG -2.6%, SDRL -2.4%, BP -1.7%, PBR 3%
Other news: Z -5.9% (following TRLA earnings/update), WES -4.6% (announces public offering of 7.5 mln common units ), INGN -3.4% (prices 2,100,775 shares of its common stock at $21.50 per share in a secondary offering), OII -3% (filed for offering of senior debt securities), CMRX -2.7% ( files for $150 mln offering of common stock; announces commencement of public offering of ~$105 mln of its common stock ), SWHC -2.7% (following RGR results), AKR -2.1% (announces sale of 3.4 mln common shares), TWTR -1.5% (CNBC reports two key engineers plan to resign), SHLD -1.5% (announces filing of prospectus supplement for rights offering of units consisting of senior unsecured notes and warrants)
Analyst comments: CGG -5.8% (initiated with a Underweight at JP Morgan), ACCO -3.3% (downgraded to Hold from Buy at KeyBanc Capital Mkts), ALK -1.6% (downgraded to Underweight from Neutral at JP Morgan), EVOL -1.5% (downgraded to Neutral from Buy at B. Riley & Co), BWS -1% (initiated with a Underweight at Morgan Stanley), CEO -1% (downgraded to Hold from Buy at Jefferies).
Gapping up In reaction to strong earnings/guidance: MOBL +11.7%, QTM +11.5%, ALU +10.2%, LOPE +9.9%, FLTX +9.2%, FORM +8.2%, CALX +7.5%, HOS +7.5%, TTWO +7.5%, CJES +6.3%, TASR +6.3%, RNG +5.1%, PPC +4.5%, AMAG +4.4%, ACHC +3.8%, CAVM +3.8%, V +3.5%, JDSU +3.3%, ARRS +3%, LLL +3%, FFIV +2.9%, NCIT +2.9%, CAR +2.9%, INCY +2.8%, DWA +2.7%, CRUS +2.6%, CLD +2.6%, VPRT +2.6%, ESV +2.4%, CEMP +2.2%, IQNT +2.1%, HST +2%, MET +1.8%, NEWP +1.8%, VECO +1.8%, ORN +1.8%, MA +1.7%, SLCA +1.6%, MMYT +1.6%, DRIV +1.4%, SPRT +1.4%, ALLE +1.4%, CRR +1.4%, EQIX +1.3%, LNC +1.3%, LOCK +1.2%, GBX +1.2%, MDXG +1.2%, COP +1.2%, NGD +1.2%, ARII +1.1%, ALDW +1.1%, NEO +1.1%, EPD +1.1%, QUIK +1%, .
M&A news: PDII +92% (Digirad delivers letter to PDI expressing willingness to acquire the company at a premium to current market price in combination of cash and stock )
Other news: LAKE +42.5% (provides update on business activity relating to Ebola crisis; The co has been experiencing significant interest globally for its ChemMAX and MicroMAX protective suit lines), APT +16.6% (following LAKE Ebola update), IBIO +14.7% (in symp with LAKE announcement), LOPE +9.9% (Board formed an independent committee to explore options aimed at enhancing stockholder value), FORM +8.2% (announced Mike Slessor will become CEO starting fiscal 2015), HOS +7.5% (Board authorized $150 mln share repurchase program), NVAX +7.2% (U.S. FDA Grants Fast Track Designation to Novavax' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M), NAVB +5.1% (announces scientific presentations of results from Lymphoseek studies at the European Association of Nuclear Medicine), BBSI +5% (following 50%+ decline yesterday on earnings), LVLT +3.8% (Level 3 to join S&P 500 11/4 ), CBSO +3.2% (co's Board has approved a special dividend on the company's common stock of ~$547.7 million, or $4.56 per share), TBIO +2.9% (co and University of Melbourne collaborate to further validate ability of multiplexed ICE COLD-PCRTM)
Analyst comments: NFX +0.8% (upgraded to Buy from Hold at Societe Generale)